KOSDAQ - Delayed Quote KRW

Hugel, Inc. (145020.KQ)

346,000.00
+2,000.00
+(0.58%)
At close: 3:30:14 PM GMT+9
Currency in KRW All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
373,046,885.99
373,046,885.99
319,699,941.15
281,675,135.06
231,859,108.19
Cost of Revenue
85,871,389.42
85,871,389.42
73,537,109.93
62,818,252.47
54,778,657.64
Gross Profit
287,175,496.57
287,175,496.57
246,162,831.22
218,856,882.59
177,080,450.55
Operating Expense
120,946,326
120,946,326
128,381,044
117,478,389
81,469,107
Operating Income
166,229,170.57
166,229,170.57
117,781,787.22
101,378,493.59
95,611,343.55
Net Non Operating Interest Income Expense
13,550,533.47
13,550,533.47
32,348,317.74
8,385,580.35
1,494,585.50
Pretax Income
165,179,546.91
165,179,546.91
133,269,750.42
73,086,582.12
87,442,351.01
Tax Provision
22,044,964.06
22,044,964.06
35,609,450.79
9,178,329.67
28,273,333.77
Net Income Common Stockholders
135,813,576.90
135,813,576.90
93,076,068.77
57,331,825.84
57,730,176.34
Basic EPS
12.52k
--
8.22k
4.81k
4.73k
Diluted EPS
11.99k
--
7.93k
4.74k
4.66k
Basic Average Shares
10,847.73
--
11,327.26
11,916.82
12,197.38
Diluted Average Shares
11,329.13
--
11,731.29
12,087.67
12,393.77
Total Operating Income as Reported
166,229,170.61
166,229,170.61
117,781,785.95
101,378,493.27
95,611,343.31
Rent Expense Supplemental
486,293
486,293
630,349
425,325
415,670
Total Expenses
206,817,715.42
206,817,715.42
201,918,153.93
180,296,641.47
136,247,764.64
Net Income from Continuing & Discontinued Operation
135,813,576.90
135,813,576.90
93,076,068.77
57,331,825.84
57,730,176.34
Normalized Income
150,634,991.31
150,634,991.31
106,043,132.61
89,848,548.27
62,523,056.98
Interest Income
14,729,013
14,729,013
17,587,474
11,497,158
5,215,591
Interest Expense
1,178,480
1,178,480
2,936,265
3,111,578
3,721,006
Net Interest Income
13,550,533.47
13,550,533.47
32,348,317.74
8,385,580.35
1,494,585.50
EBIT
166,358,026.91
166,358,026.91
136,206,015.42
76,198,160.12
91,163,357.01
EBITDA
181,393,801.91
181,393,801.91
150,066,386.42
90,192,287.12
105,462,458.01
Reconciled Cost of Revenue
85,871,389.42
85,871,389.42
73,537,109.93
62,818,252.47
54,778,657.64
Reconciled Depreciation
15,035,775
15,035,775
13,860,371
13,994,127
14,299,101
Net Income from Continuing Operation Net Minority Interest
135,813,576.90
135,813,576.90
93,076,068.77
60,558,316.78
56,506,088.35
Total Unusual Items Excluding Goodwill
-17,104,144
-17,104,144
-17,695,188
-33,496,815
-8,892,118
Total Unusual Items
-17,104,144
-17,104,144
-17,695,188
-33,496,815
-8,892,118
Normalized EBITDA
198,497,945.91
198,497,945.91
167,761,574.42
123,689,102.12
114,354,576.01
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-2,282,729.59
-2,282,729.59
-4,728,124.16
-4,206,583.51
-2,875,149.37
12/31/2021 - 12/24/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

086900.KQ Medy-Tox Inc.
168,200.00
+2.56%
 
214450.KQ PharmaResearch Co., Ltd.
423,500.00
+6.41%
 
326030.KQ 326030.KQ,0P0001K80D,79657
86,400.00
+0.12%
 
207940.KQ 207940.KQ,0P000196OG,69248
835,000.00
-1.76%
 
068270.KQ Celltrion Inc
187,900.00
0.00%
 
068270.KS Celltrion, Inc.
154,300.00
0.00%
 
207940.KS Samsung Biologics Co.,Ltd.
1,005,000.00
+0.50%
 
397030.KQ AprilBio Co.,Ltd.
16,800.00
+5.00%
 
141080.KQ LigaChem Biosciences Inc.
98,300.00
-1.40%
 
IVBXF Innovent Biologics, Inc.
5.94
0.00%